SOLIGENIX, INC. (SNGX): Nasdaq/NYSE listing notice — Soligenix regains Nasdaq compliance; Panel Monitor imposed for one year

SOLIGENIX, INC.

Received Nasdaq letter on May 23, 2023 confirming regained compliance with Shareholders' Equity Requirement.
Compliance achieved as of May 9, 2023 through recent capital raising activities.
Panel Monitor imposed for one year; must notify Nasdaq if bid price falls below $1.00 or violates other listing rules.
Previously satisfied Minimum Bid Price Requirement on Feb 24, 2023 after ten consecutive sessions above $1.00.
Nasdaq delisting matter closed; common stock (SNGX) continues trading on The Nasdaq Capital Market.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

SOLIGENIX, INC. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)).

Exchange: nasdaq
Notice: compliance regained
Deficiency: stockholders equity
Rules: 5550(b)

Exact text from the filing

April 6, 2023, Nasdaq granted the Company’s request for an extension of the deadline by which it must regain compliance with the Shareholders’ Equity Requirement from March 31, 2023 to May 15, 2023. The Company is working diligently to satisfy, and intends to regain compliance with, the Shareholders’ Equity Requirement; however, there can be no assurance that the Company will be able to do so prior to the deadline established by Nasdaq, or at all, or that the Company’s common stock will remain listed on The Nasdaq Capital Market. New Disclosure As of the close of the market on May 9, 2023

View on SEC.gov

Browse all listing & compliance notices →

SOLIGENIX, INC. filing history →

Source: SEC EDGAR

accession 0001558370-23-010537

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.